Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique

European Journal of Cancer Prevention

Volumn 16, Issue 2, 2007, Pages 108-115

  Guntupalli, J Naga Raju ^a   Padala, Sarita ^a   Gummuluri, A V Ramana Murty ^a   Muktineni, Ravi Kumar ^a   Byreddy, Seetharami Reddy ^a   Sreerama, Lakshminarayana ^a   Kedarisetti, Prema Chand ^a   Angalakuduru, Durga Prasad ^a   Satti, Bhuloka Reddy ^a   Venkatathri, Vijayan ^d   Pullela, V B Rama Lakshmi ^b   Gavarasana, Satyanarayana ^c  

^a ANDHRA UNIVERSITY   (India)

^b ANDHRA MEDICAL COLLEGE   (India)

^c Lions Cancer Hospital   (India)

^d INSTITUTE OF PHYSICS   (India)

Author keywords

Benign hypertrophic and cancerous tissues; Normal; Particle induced X ray emission technique; Prostate; Trace elemental analysis

Indexed keywords

BROMINE; CALCIUM; CHLORINE; CHROMIUM; COPPER; IRON; MANGANESE; NICKEL; POTASSIUM; SELENIUM; TITANIUM; TRACE ELEMENT; ZINC;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENERGY TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE TUMOR; PROTON RADIATION; RADIATION BEAM; RADIATION ENERGY; X RAY;

HUMANS; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SPECTROMETRY, X-RAY EMISSION; TRACE ELEMENTS;

EID: 33846985642     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000228409.75976.b6     Document Type: Article

References (83)

1. Abalea V, Cillard J, Dubos MP, Anger JP, Cillard P, Morel I (1998). Iron-induced oxidative DNA damage and its repair in primary rat hepatocytes culture. Carcinogenesis 19:1053-1059.
2. Abate-Shen C, Shen MM (2000). Molecular genetics of prostate cancer. Genes Dev 14:2410-2434.
3. Akanle OA, Akintanmide A, Durosinmi MA, Oluwole AF, Spyrou NM (1999). Elemental analysis of blood of Nigerian hypertensive subjects. Biol Trace Elem Res 71:611-616.
4. Armendariz AD, Vulpe CD (2003). Nutritional and genetic copper overload in a mouse fibroblast cell line. J Nutr 133:203E-282E.
5. Bhuloka Reddy S, John Charles M, Ravi Kumar M, Seetharami Reddy B, Anjaneyulu Ch, Naga Raju GJ, et al. (2002). Trace elemental analysis of adenoma and carcinoma thyroid by PIXE method. Nucl Instrum Methods B 196:333-339.
6. Bhuloka Reddy S, John Charles M, Naga Raju GJ, Vijayan V, Seetharami Reddy B, Ravi Kumar M, Sundareswar B (2003). Trace elemental analysis of carcinoma kidney and stomach by PIXE method. Nucl Instrum Methods B 207: 345-355.
7. Bhuloka Reddy S, John Charles M, Naga Raju GJ, Seetharami Reddy B, Seshi Reddy T, Rama Lakshmi PVB, Vijayan V (2004). Trace elemental analysis of cancer-afflicted intestine by PIXE technique. Biol Trace Elem Res 102:265-282.
8. Cerutti PA (1994). Oxy-radicals and cancer. Lancet 334:862-873.
9. Chandra S, Chandra RK (1986). Nutrition, immune response, and outcome. Prog Food Nutr Sci 10:1-65.
10. Chau N, Benamghar L, Pham QT, Teculescu D, Rebstock E, Mur JM (1993). Mortality of iron miners in Lorraine (France): relations between lung function and respiratory symptoms and subsequent mortality. Br J Ind Med 50: 1017-1031.
11. Chaudiere J, Wilhelmsen EC, Tappel AL (1984). Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. J Biol Chem 259:1043-1050.
12. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J Am Med Asoc 276:1957-1985.
13. Cohen MD, Kargacin B, Klein CB, Costa M (1993). Mechanisms of chromium carcinogenicity and toxicity. Crit Rev Toxicol 23:255-281.
14. Cunzhi H, Jiexian J, Xianwen Z, Jingang G, Shumin Z, Lili D (2003). Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res 94:113-122.
15. Cutts DA, Maguire RP, Stedman JD, Leenders KL, Spyrou NM (1999). A comparative study in Alzheimer's and normal brains of trace element distribution using PIXE and INA analyses and glucose metabolism by positron emission tomography. Biol Trace Elem Res 71-72:541-549.
16. Denkhaus E, Salnikow K (2002). Nickel essentiality, toxicity, and carcinogenicity. Crit Rev Onclo Hemat 42:35-56.
17. Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD (2003). Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 52:794-804.
18. Dong Y, Zhang H, Hawthorn L, Ganther HE, Ip C (2003). Delineation of the molecular basis of selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 63:52-59.
19. Ektessabi A, Shikine S, Kitamura N, Rokkum M, Johansson C (2001). Distribution and chemical states of iron and chromium released from orthopedic implants into human tissues. X-Ray Spectrom 30:44-48.
20. Elinder CG, Friberg L, Kjellstrom T, Nordberg G, Oberdoerster G (1994). Biological monitoring of metals. International Programme on Chemical Safety (IPCS). Geneva: WHO.
21. Feng P, Liang TY, Li TL, Guan ZX, Zou J, Franklin R, et al. (2000). Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 4:31-36.
22. Feustel A, Wennrich R (1986). Zinc and cadmium plasma and erythrocyte levels in prostate carcinoma, BPH, urological malignancies, and inflammations. Prostate 8:75-79.
23. Fraker PJ, King LE, Laakko T, Vollmer TL (2000). The dynamic link between the integrity of the immune system and zinc status. J Nutr 130:1399S-1406S.
24. Freeman N, Lioy PJ (1997). Exposure to chromium dust from homes in a chromium surveillance project. Arch Environ Health 52:213-226.
25. Galaris D, Evangelou A (2002). The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit Rev Oncol Hematol 42:93-103.
26. Geraki K, Farquharson MJ, Bradley DA (2002). Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys Med Biol 47:2327-2339.
27. Giacosa A, Filiberti R (1996). Free radicals, oxidative damage and degenerative diseases. Eur J Cancer Prev 5:307-312.
28. Gotti RA, Good RA (1971). Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28:89-98.
29. Harper ME, Glynne-Jones E, Goddard L, Thurston VJ, Griffiths K (1996). Vascular endothelial growth factor (VEGF) expression in prostatic tumors and its relationship to neuroendocrine cells. Br J Cancer 74:910-916.
30. Hartwig A, Mullenders LHF, Schlepegrell R, Kasten U, Beyersmann D (1994). Nickel (II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 54:4045-4051.
31. Hayes RB (1997). The carcinogenicity of metals in humans. Cancer Causes Control 8:371-386.
32. Hu GF (1998). Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69:326-335.
33. International Agency for Research on Cancer (1990). IARC monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol. 49, Chromium, nickel and welding. Lyon, France: International Agency for Research on Cancer. p. 677.
34. Iguchi K, Hamatake M, Ishida R, Usami Y, Adachi T, Yamamoto H, et al. (1998). Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem 253:766-770.
35. Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatemastu M, et al. (2001a). Aminopeptidase N regulated by zinc in human prostate participated in tumor cell invasion. Int J Cancer 92:49-54.
36. Ishii K, Usui S, Sugimura Y, Yamamoto H, Yoshikawa K, Hirano K (2001b). Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull 24:226-230.
37. Jendryczko A, Crozdz M, Tomala J, Magner K (1986). Copper and zinc concentrations, and superoxide dismutase activities in malignant and nonmalignant tissues of female reproductive organs. Neoplasma 33: 239-244.
38. Jiang C, Wang Z, Ganther H, Lu J (2002). Distinct effects of methylseleninic acid versus selenite on apoptosis cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther 12:1059-1066.
39. Kasprzak KS (1991). The role of oxidative damage in metal carcinogenicity. Chem Res Toxicol 4:604-615.
40. Kersey JH, Spetor BD, Good RA (1973). Immunodeficiency and cancer. Adv Cancer Res 18:211-230.
41. Kim LY, Standtman TC (1997). Inhibition of NF-kB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci 94:12904-12907.
42. Klein CB, Frenkel K, Costa M (1991). The role of oxidative processes in metal carcinogenesis. Chem Res Toxicol 4:592-604.
43. Knight JA (2000). Review: free radicals, antioxidants and the immune system. Ann Clin Lab Sci 30:145-158.
44. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2003). Iron concentrations in intestinal cancer tissue and in colon and rectum polyps. Biol Trace Elem Res 95:19-28.
45. Langard S (1990). One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Ind Med 17: 189-215.
46. Langard S, Andersen A, Ravnestad J (1990). Incidence of cancer among ferrochromium and ferrosilicon workers: an extended observation period. Br J Ind Med 47:14-19.
47. Leach SD, Scatena CD, Keefer CJ, Goodman HA, Song SY, Yang L, et al. (1998). Negative regulation of Weel expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res 58: 3231-3236.
48. Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, et al. (1995). Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15:2547-2557.
49. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P (1999). Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40: 200-207.
50. Lieu PT, Heiskala M, Peterson PA, Yang Y (2001). The roles of iron in health and disease. Mol Aspects Med 22:1-87.
51. Maxwell JA, Campbell JL, Teesdale WJ (1989). The Guelph PIXE software package. Nucl Instum Methods B 43:218-230.
52. Maxwell JA, Campbell JL, Teesdale WJ (1995). The Guelph PIXE software package II. Nucl Instrum Methods B 95:407-421.
53. Menter D, Sabichi A, Lippman S (2000). Selenium effects on prostate cell growth. Cancer Epidemiol Biomark Prev 9:1171-1182.
54. Mertz W (1969). Chromium occurrence and function in biological systems. Physiol Rev 49:163-239.
55. Minigari MC, Moretta A, Moretta L (1998). Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today 19:153-157.
56. Naga Raju GJ, John Charles M, Bhuloka Reddy S, Sarita P, Seetharami Reddy B, Rama Lakshmi PVB, Vijayan V (2005). Trace elemental analysis in a cancer-afflicted tissues of penis and testis by PIXE technique. Nucl Instrum Methods B 229:457-464.
57. Nayak SB, Bhat VR, Upadhyay D, Udupa SL (2003). Copper and ceruloplasmin status in serum of prostate and colon. Indian J Physiol Pharmacol 47: 108-110.
58. Neve J (1991). Physiological and nutritional importance of selenium. Experentia 47:187-193.
59. Ouyang SY, Li SL (2000). Investigation of trace elements in hair of patients with prostate carcinoma, benign prostatic hypertrophy, and normal controls. Hunan Yi Ke Da Xue Xue Bao 25:279-280.
60. Patstone G, Maher P (1996). Copper and calcium binding motifs in the extracellular domains of fibroblast growth factor receptors. J Biol Chem 271:3343-3346.
61. Prasad AS (2000a). Effects of zinc deficiency on immune functions. J Trace Elem Exp Med 13:1-20.
62. Prasad AS (2000b). Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 182:S62-S68.
63. Redman C, Scott JA, Baines AT, Basye JL, Clark LC, Calley C, et al. (1998). Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 125:103-110.
64. Rink L, Gabriel P (2000). Zinc and the immune system. Proc Nutr Soc 59: 541-552.
65. Rink L, Gabriel P (2001). Extracellular and immunological actions of zinc. Biometals 14:367-383.
66. Rojas E, Herrera LA, Poirier LA, Ostrosky-Wegman P (1999). Are metals dietary carcinogens? Mutat Res 443:157-181.
67. Ross RK, Henderson BE (1994). Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86:252-254.
68. Salnikow K, Su W, Blagosklonny M, Costa M (2000a). Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species independent mechanism. Cancer Res 60:3375-3378.
69. Salnikow K, Blagosklonny M, Ryan H, Johnson R, Costa M (2000b). Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 60:38-41.
70. Sawyer DT (1987). In: Martell AE, Sawyer DT, editors. Oxygen complexes and oxygen activation by transition metals. New York: Plenum Press. pp. 131-148.
71. Sharma VP, Parikh V, Bhandari LM (1984). Serum copper and zinc levels in patients with solid tumors. Indian J Cancer 21:1-6.
72. Sies H (1996.) Antioxidants in disease, mechanisms and therapy. New York: Academic Press.
73. Spiro TG (1980). Metal ion activation of dioxygen. New York: John Wiley & Sons.
74. Stohs SJ, Bagchi D (1995). Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321-336.
75. Toyokuni S (1996). Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20:553-566.
76. Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, et al. (2002). Zinc inhibits nuclear factor-kB activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res 8:3579-3583.
77. Weinberg ED (1996). The role of iron in cancer. Eur J Cancer Prev 5:19-36.
78. Weinberg ED (1999). Iron loading and disease surveillance. Emerg Infect Dis 5:346-352.
79. Wild CP, Andersson C, O'Brien NM, Wilson L, Woods JA (2001). A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. Br J Nutr 86:37-53.
80. Wu HY (1988). Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma. Zhonghua Zhong Liu Za Zhi 10:335-338.
81. Yoshida S, Ektessabi A, Fujisawa S (2001). XAFS spectroscopy of a single neutron from a patient with Parkinson's disease. J Synchrotron Radiat 8:998-1000.
82. Zaichick V, Sviridova TV, Zaichick SV (1997). Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29:565-574.
83. Zuin G, Principi N (1997). Trace elements and vitamins in immunomodulation in infancy and childhood. Eur J Cancer Prev 6:S69-S77.